Condition
Low Testosterone
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results80% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (1)
P 1 (1)
P 2 (3)
P 4 (1)
Trial Status
Completed4
Withdrawn1
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07740161Not ApplicableCompleted
A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Male Fertility
NCT04975334Phase 1Completed
Opioid Antagonism in Hypogonadotropic Hypogonadism
NCT00163566Phase 2Completed
Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80
NCT02381288Phase 2TerminatedPrimary
Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone
NCT01689896Phase 4WithdrawnPrimary
Testosterone and Pain Sensitivity
NCT01386567Phase 2Completed
A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203
Showing all 6 trials